Table II.
Hematological profile | 6h Exposure | 15 day Exposure | ||
---|---|---|---|---|
Control | Milk Exo | Control | Milk Exo | |
WBC | 5.7 ± 2.5 | 6.5 ± 1.6 | 5.7 ± 1.7 | 7.0 ± 2.0 |
HGB | 14.0 ± 1.2 | 13.5 ± 0.9 | 14.0 ± 0.3 | 13.8 ± 0.6 |
HCT | 44.0 ± 3.5 | 41.5 ± 3.4 | 43.3 ± 2.1 | 42.3 ± 1.9 |
MCV | 60.8 ± 1.0 | 59.0 ± 1.8 | 45.5 ± 29.0 | 59.3 ± 1.7 |
MCHC | 31.8 ± 0.5 | 32.4 ± 1.0 | 32.3 ± 2.3 | 32.8 ± 0.5 |
Platelet Count | 689.0 ± 145.8 | 605.8 ± 433.2 | 755.7 ± 134.9 | 772.8 ± 85.8 |
Neutrophils | 12.0 ± 3.5 | 32.7 ± 35.8 | 11.5 ± 3.0 | 13.5 ± 8.4 |
Lymphocytes | 84.5 ± 4.5 | 50.8 ± 40.4 | 86.0 ± 2.8 | 81.0 ± 7.4 |
Female Sprague Dawley rats (6-7) weeks old were provided control diet (AIN 93M) and water ad libitum and treated with milk-derived exosomes (25 mg/kg, b. wt.) by oral gavage for 6 h or 15 days, once daily. At euthanasia blood was collected and analyzed using an automated AU640® Chemistry Analyzer (Beckman Coulter, Inc., Brea, CA, USA) by Antech diagnostics. Data represent average and Sprague-Dawley of four animals. Statistical analysis was performed by student t-test and no significant change was observed in milk exosome treated animals compared to control group.